ArticleRheumatology international2019

Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada.

Jason Foo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.